Ivermectin and COVID-19 Review: Updated January 2021

As of January 2021, there are 43 on-going trials on Ivermectin and COVID-19 registered on ClinicalTrials.gov. Ivermectin is an anti-parasitic medication widely used in low- and middle-income countries to treat parasitic worm infections in adults and children. It’s been used for decades for this purpose by over 3.7 billion people, and is considered safe and effective. It has an increasing list of indications due to its antiviral and anti-inflammatory properties, and is included on the WHO’s Model List of Essential Medicines. Ivermectin and COVID-19 Updates: Jan 23, 2021: Researchers at Oxford University are planning the first, large high-quality trial of Ivermectin that has been credited with dramatically reducing Covid-19 deaths in the developing world. The PRINCIPLE trial is aiming to find a drug that works soon after virus symptoms appear in a patient, and one that is most effective during the primary stages of the illness, The Times reported . Jan 19, 2021: A pilot study publishe